Kestrel Investment Management’s PharMerica Corporation PMC Stock Holding History

Kestrel Investment Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-251,050	Closed	-$5.2M	–	56
2014 Q4	$5.2M	Sell	251,050 -2,800	-1%	-$66.5K	0.69%	46
2014 Q3	$6.2M	Sell	253,850 -389,225	-61%	-$10.3M	0.88%	46
2014 Q2	$18.4M	Sell	643,075 -12,825	-2%	-$357K	2.29%	19
2014 Q1	$18.4M	Sell	655,900 -16,350	-2%	-$401K	2.28%	19
2013 Q4	$14.5M	Sell	672,250 -136,900	-17%	-$2.49M	1.78%	27
2013 Q3	$10.7M	Sell	809,150 -32,700	-4%	-$441K	1.1%	42
2013 Q2	$11.7M	Buy	+841,850	New	+$11.9M	1.29%	39

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CCM

Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

LCP

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Kestrel Investment Management's PMC Position: Q1 2015 in Review

Kestrel Investment Management sold out of PharMerica Corporation (PMC) in Q1 2015, closing a stake of 251,050 shares — an estimated $5.2M sold.

Kestrel Investment Management first reported a position in PMC in Q2 2013 and held it in 7 quarters. The position peaked at $18.4M in Q2 2014. 158 funds tracked by Wall St. Rank hold PMC as of Q1 2015.

Kestrel Investment Management reported no remaining PharMerica Corporation position as of Q1 2015 after selling out during the quarter.
Kestrel Investment Management sold 251,050 PharMerica Corporation shares in Q1 2015, an estimated $5.2M.
Kestrel Investment Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 7 quarters.
Kestrel Investment Management's PharMerica Corporation position peaked at $18.4M in Q2 2014.
158 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2015.

Based on Kestrel Investment Management's 13F filing for Q1 2015, filed 13 May 2015.